Doctorglasses Chain Co

Doctorglasses Chain Co EBITDA Margin

The EBITDA Margin of Doctorglasses Chain Co (300622.SZ) as of Nov 11, 2026 is 14.63 %. In the previous year, EBITDA Margin was 11.99 % — a change of 22.04% (higher).

EBITDA Margin

14.63 %

YoY

22.04%

Last updated:

EBITDA Margin of Doctorglasses Chain Co is 2025 14.63 % . EBITDA Margin of Doctorglasses Chain Co was 2024 11.99 % . It decreases by 22.04% higher compared to the previous year.

The Doctorglasses Chain Co EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2018
15.36 CNY
Jan 1, 2019
16.51 CNY
Jan 1, 2020
17.25 CNY
Jan 1, 2021
14.01 CNY
Jan 1, 2022
10.04 CNY
Jan 1, 2023
15.27 CNY
Jan 1, 2024
11.99 CNY
Jan 1, 2025
14.63 CNY
The Doctorglasses Chain Co EBITDA Margin history
YEAREBITDA MarginYoY
14.63 %+22.04%
11.99 %-21.52%
15.27 %+52.06%
10.04 %-28.29%
14.01 %-18.82%
17.25 %+4.50%
16.51 %+7.49%
15.36 %-5.15%
16.19 %+2.14%
15.85 %+14.69%
13.82 %-6.85%
14.84 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Doctorglasses Chain Co Stock analysis

What does Doctorglasses Chain Co do? Doctorglasses Chain Co., Ltd. generates revenue through its chain of optical retail stores offering frames, lenses, sunglasses, reading glasses, contact lenses, and care solutions, alongside optometry and optics services. The company operates under the brands President optical, Doctor’s Glasses, zele, and Tong, selling products via direct stores, e-commerce, and wholesale channels. Its primary customer segments include individuals seeking eyewear solutions and optometry services, with a focus on retail and online sales channels. The firm’s product portfolio spans prescription and non-prescription eyewear, including specialized options like reading glasses and contact lenses, supported by care solutions for lens maintenance. Brands such as President optical and Doctor’s Glasses target diverse consumer segments, while zele and Tong cater to specific market niches. Sales through direct stores and e-commerce platforms drive the majority of revenue, complemented by wholesale distribution to other retailers. Doctorglasses Chain Co., Ltd. serves both individual consumers and business clients through its retail and wholesale models. The company’s revenue streams are derived from the sale of eyewear products and associated services, with a strong emphasis on brand-specific product lines. Direct store sales and e-commerce represent the most significant distribution channels, ensuring broad market coverage across its operational regions. Doctorglasses Chain Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Doctorglasses Chain Co stock

EBITDA Margin of Doctorglasses Chain Co is 14.63 % in 2025.

EBITDA Margin of Doctorglasses Chain Co changed from 11.99 % to 14.63 %, representing a 22.04% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Doctorglasses Chain Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Doctorglasses Chain Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Doctorglasses Chain Co

All Key Metrics — Doctorglasses Chain Co